The role of LLT1 in the liver and in hepatocellular carcinoma.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Janet E Dancey

NCIC Clinical Trials Group - Canadian Collaborating Clinical Trials Network

Liver and intrahepatic bile ducts

Mark Thursz

Prolifica (Prevention of Liver Fibrosis and Cancer in Africa)

Liver and intrahepatic bile ducts

Pathology

Richard T D'Aquila

Third Coast Center for AIDS Research

Liver and intrahepatic bile ducts

Pathology

Xin Wei Wang

The Identification of Human Hepatocellular Carcinoma Metastasis Genes

Liver and intrahepatic bile ducts

Pathology

William G Nelson

Chronic exposure to aflatoxin and the risk of liver cancer, fatty liver disease, liver fibrosis, and diabetes

Liver and intrahepatic bile ducts

Pathology

Geoffrey D Girnun

Metabolic control of hepatocellular carcinoma by PGC1alpha

Liver and intrahepatic bile ducts

Pathology

Jean William Pape

GHESKIO HIV Clinical Trial Unit

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri

Anneke Catharina Hesseling

PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma

Hematology and hematologic malignancies